Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-13-033782

Options or other derivatives

  • Chief Executive Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
DEES H CRAIG Chief Executive Officer 2013-08-19 Grant or award · Stock Option (right to buy) +50,000 50,000 D
Loading xslF345X03/doc1.xml…